Autologous tumor lysate–pulsed DC vaccination (DCVax-L) in conjunction with TLR agonists (poly-iclc) was already evaluated for safety in newly diagnosed and recurrent glioblastoma patients in 2010https://t.co/UOMlvQNHPr
Let's follow this rabbit down the hole 💪🏻
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) March 2, 2024
And LC
Sorry, DanishDud, but Ex already put your nutty post in its place